Places

Home Places

Burford Capital passes evidence of market manipulation to US regulators

Burford Capital Ltd’s (LON:BUR) claims that its shares have been the victim of market manipulation by short-seller Muddy Waters have been passed to the...

Thor Mining advances after big news from Big Sandy

Thor Mining PLC (LON:THR) shares advanced on Monday after the firm reported more positive drilling results from the Big Sandy project in Arizona, USA. The...

Clear Leisure shares slump as it reveals disagreement with joint venture partner, 64Bit Ltd

Investment company Clear Leisure PLC PLC (LON:CLPP) saw its shares slump 19% to 0.255p after it revealed a US$100,000 investment in an Israeli technology...

NSF posts wider loss after failed attempt to buy Provident Financial

Non-Standard Finance PLC (LON:NSF) said it is “cautiously optimistic” about the full-year outlook as it posted a wider first-half loss due to costs related...

Arc Minerals extends mineralised footprint at Cheyeza East target in Zambia

Arc Minerals Ltd (LON:ARCM) has released further drill results from its maiden exploration drill programme at the Cheyeza East target area in Zambia. The company also provided an...

Scancell Holdings lays groundwork for pivotal year

Scancell Holdings PLC (LON:SCLP) described the 12 months to the end of April as a “busy and productive year” – one in which the...

BHP hikes dividend but not as much as expected

BHP Group PLC (LON:BHP) unveiled a record dividend payment on Tuesday but it was not as much as analysts had wanted.  Underlying attributable profit of...

Argo Blockchain surges as it inks deal to expand electricity supply by 357%

Argo Blockchain PLC (LON:ARB) shares surged on Tuesday as it signed a deal to increase its electricity supply by 357%. The cryptocurrency miner said on...

Infrastructure group Costain sees profits plunge in first half

Profits at Costain Group PLC (LON:COST) more than halved in the first half of the year amid a dearth of big contract wins. Revenue slipped...

AstraZeneca’s cancer drug combo stumbles in phase III lung cancer trial

After a run of trial successes, AstraZeneca PLC (LON:AZN) was a due a failure, and so that proved to be the case today. The FTSE...
20,830FansLike
2,508FollowersFollow
14,700SubscribersSubscribe
- Advertisement -

Don't Miss